APOTEX CORP Company Profile
✉ Email this page to a colleague
What is the competitive landscape for APOTEX CORP, and what generic and branded alternatives to APOTEX CORP drugs are available?
APOTEX CORP has twelve approved drugs.
There is one tentative approval on APOTEX CORP drugs.
Summary for APOTEX CORP
US Patents: | 0 |
Tradenames: | 10 |
Ingredients: | 10 |
NDAs: | 12 |
Patent Litigation for APOTEX CORP: | See patent lawsuits for APOTEX CORP |
PTAB Cases with APOTEX CORP as petitioner: | See PTAB cases with APOTEX CORP as petitioner |
Drugs and US Patents for APOTEX CORP
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apotex Corp | NARATRIPTAN | naratriptan hydrochloride | TABLET;ORAL | 091373-002 | Apr 22, 2011 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Apotex Corp | RILUZOLE | riluzole | TABLET;ORAL | 091300-001 | Jun 18, 2013 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Apotex Corp | VERAPAMIL HYDROCHLORIDE | verapamil hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 200878-003 | Apr 20, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.